Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
Journal of the American Heart Association
|
July 19, 2021
Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE Trial
Mikkel Jürgens, Morten Schou, Philip Hasbak, et al.
Journal of Cardiac Failure
|
November 26, 2018
Right Ventricular and Pulmonary Vascular Function are Influenced by Age and Volume Expansion in Healthy Humans
Emil Wolsk, Rine Bakkestrøm, Charlotte Burup Kristensen, et al.
BMC Geriatrics
|
March 22, 2022
Association between early detected heart failure stages and future cardiovascular and non-cardiovascular events in the elderly (Copenhagen Heart Failure Risk Study)
Saaima Parveen, Bochra Zareini, Anojhaan Arulmurugananthavadivel, et al.
BMJ Open
|
November 30, 2019
Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial)
Mikkel Jürgens, Morten Schou, Philip Hasbak, et al.
Diabetes
|
January 21, 2022
Randomized Controlled Trial of the Hemodynamic Effects of Empagliflozin in Patients With Type 2 Diabetes at High Cardiovascular Risk: The SIMPLE Trial
Emil Wolsk, Mikkel Jürgens, Morten Schou, et al.
Diabetes, Obesity & Metabolism
|
December 22, 2022
Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial
Hertzel C Gerstein, Emil Wolsk, Brian Claggett, et al.
JACC. Heart Failure
|
March 11, 2019
Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients With Preserved Ejection Fraction
Emil Wolsk, David Kaye, Jan Komtebedde, et al.
JACC. Heart Failure
|
July 8, 2026
Medium-Chain Triacylglycerol Improves Cardiac Function in Chronic Heart Failure: A Randomized Cross-Over Trial
Josephine M Kanta, Amalie S Frederiksen, Amalie London, et al.
Cardiovascular Diabetology
|
October 13, 2020
Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trial
Magnus O Wijkman, Brian Claggett, Rafael Diaz, et al.
Circulation
|
October 18, 2017
Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus
Emil Wolsk, Brian Claggett, Rafael Diaz, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
Journal of the American Heart Association
|
July 19, 2021
Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE Trial
Mikkel Jürgens, Morten Schou, Philip Hasbak, et al.
Journal of Cardiac Failure
|
November 26, 2018
Right Ventricular and Pulmonary Vascular Function are Influenced by Age and Volume Expansion in Healthy Humans
Emil Wolsk, Rine Bakkestrøm, Charlotte Burup Kristensen, et al.
BMC Geriatrics
|
March 22, 2022
Association between early detected heart failure stages and future cardiovascular and non-cardiovascular events in the elderly (Copenhagen Heart Failure Risk Study)
Saaima Parveen, Bochra Zareini, Anojhaan Arulmurugananthavadivel, et al.
BMJ Open
|
November 30, 2019
Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial)
Mikkel Jürgens, Morten Schou, Philip Hasbak, et al.
Diabetes
|
January 21, 2022
Randomized Controlled Trial of the Hemodynamic Effects of Empagliflozin in Patients With Type 2 Diabetes at High Cardiovascular Risk: The SIMPLE Trial
Emil Wolsk, Mikkel Jürgens, Morten Schou, et al.
Diabetes, Obesity & Metabolism
|
December 22, 2022
Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial
Hertzel C Gerstein, Emil Wolsk, Brian Claggett, et al.
JACC. Heart Failure
|
March 11, 2019
Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients With Preserved Ejection Fraction
Emil Wolsk, David Kaye, Jan Komtebedde, et al.
JACC. Heart Failure
|
July 8, 2026
Medium-Chain Triacylglycerol Improves Cardiac Function in Chronic Heart Failure: A Randomized Cross-Over Trial
Josephine M Kanta, Amalie S Frederiksen, Amalie London, et al.
Cardiovascular Diabetology
|
October 13, 2020
Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trial
Magnus O Wijkman, Brian Claggett, Rafael Diaz, et al.
Circulation
|
October 18, 2017
Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus
Emil Wolsk, Brian Claggett, Rafael Diaz, et al.
Page
of 6